This compound is a pharmaceutical intermediate specifically used in the synthesis of dapagliflozin analogs. It is characterized by a complex molecular structure containing multiple hydroxyl groups, ether linkages, and an aromatic ring system.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 714269-57-5
4-(Aminomethyl)piperidine
pharmaceutical intermediate
Methyl 4-aminopyridine-2-carboxylate
pharmaceutical intermediate
4'-Methylbiphenyl-2-carboxylic acid
pharmaceutical intermediate
2-Bromopropionyl chloride
pharmaceutical intermediate
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucopyranoside
pharmaceutical intermediate
(2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
pharmaceutical intermediate
(2S,3R,4S,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
GKTWLVVOULBRDU-BDHVOXNPSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@]3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC)Cl